Form 4: OrthoPediatrics CEO Gifts 1,600 Shares

Sentiment:

Insider Transaction Report


David R. Bailey, President and CEO of OrthoPediatrics Corp, reported gifting 1,600 shares of common stock on December 29, 2025.

Summary

  • David R. Bailey, President and CEO of OrthoPediatrics Corp (KIDS), reported a transaction involving the company's common stock.
  • On December 29, 2025, Mr. Bailey disposed of 1,600 shares of common stock as a bona fide gift.
  • The transaction price for these shares was $0.
  • Following this transaction, Mr. Bailey directly beneficially owns 317,555 shares of OrthoPediatrics Corp common stock.
  • This total includes 232,335 restricted stock awards.

Sentiment

Score: 5

Explanation: The filing reports a bona fide gift of shares by an insider, which is a neutral event regarding the company's operational performance or financial health. It does not indicate positive or negative sentiment towards the company's prospects.

Future Outlook

N/A

Industry Context

This filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

  • Minimal impact on shareholders due to the small number of shares gifted relative to the total outstanding shares.
  • No direct impact on employees, customers, suppliers, or creditors is indicated by this insider transaction.

Key Dates

DateDescription
12/29/2025Date of earliest transaction (gift of shares)
12/30/2025Signature date of the reporting person's attorney-in-fact

Keywords

OrthoPediatrics, KIDS, David R. Bailey, Insider Transaction, Form 4, Common Stock, Gift, CEO, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.